Jeb Phillips

Predicting the Efficacy of Immune-Based Therapies for Pediatric Solid Tumors

Expression of HLA class I and β-2-microglobulin may show how susceptible some cancers are to T-cell based immunotherapies.
February 9, 2016  |  Written by